Prakash Achaary

MMS Partners with I-ACT to Advance Children’s Clinical Trials

MMS Partners with I-ACT to Advance Children’s Clinical Trials

CANTON, Mich. (February 21, 2023) – MMS, a data-focused contract research organization (CRO) – announced its partnership with the Institute for Advanced Clinical Trials (I-ACT) to accelerate the development of life-saving therapeutics including vaccines, medicines, and medical devices for children. MMS is a sponsor of I-ACT’s Spin Challenge, a creative way to raise funds to advance MMS Partners with I-ACT to Advance Children’s Clinical Trials

Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

Award-Winning Data CRO Expands Executive Leadership

CANTON, Mich. (2/7/2023) – MMS Holdings (MMS) – an award-winning, data-focused contract research organization (CRO) – announces the expansion of its leadership team with the appointment of Chris Schoonmaker as Chief Operating Officer. This comes as the company was recognized in the 2023 Top Workplace USA awards, a national list of organizations with strong company cultures and high Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

MMS Named Michigan Top Workplace For The Second Consecutive Year

MMS Named Michigan Top Workplace For The Second Consecutive Year

CANTON, Mich. (11/21/2022) – MMS Holdings, a data-focused contract research organization (CRO), has been named a 2022 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. This is the second year that MMS has been recognized with this honor. This award is based on feedback from a confidential survey sent out MMS Named Michigan Top Workplace For The Second Consecutive Year

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused contract research organization (“CRO”), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an investment in the Company alongside MMS Founder and CEO, Dr. Uma Sharma, who will maintain a significant ownership interest. The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services

Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

MMS Holdings (MMS), an award-winning, data-focused contract research organization (CRO), announced today that it has been selected by MAPS Public Benefit Corporation (MAPS PBC) as its contract research organization for the development of a New Drug Application (NDA) for MDMA-assisted therapy for posttraumatic stress disorder (PTSD). This announcement comes on PTSD Awareness Day as the confirmatory Phase 3 trial MAPP2, the second of two Phase 3 trials conducted by MAPS PBC, finished enrollment in early May. 

MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors

MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors

MMS Holdings, a data-focused Contract Research Organization (CRO), is pleased to announce a strategic partnership with Medidata, a Dassault Systèmes company, to provide clients a full range of solutions for clinical data management (CDM) and decentralized clinical trial solutions (DCTs), including Medidata’s unified platform and Rave EDC (Electronic Data Capture).

MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

MMS Holdings Inc. (MMS) – an award-winning, data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trials platform (DCT) and DCT-enabled services. THREAD’s next-generation DCT technology enables faster, more efficient clinical trials while improving access for research participants with higher quality data capture across the life cycle of a study.